{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T01:47:10Z","timestamp":1774748830186,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T00:00:00Z","timestamp":1540080000000},"content-version":"am","delay-in-days":293,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ahj.2017.09.003","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T22:17:45Z","timestamp":1504909065000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"195","author":[{"given":"Eden","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-560X","authenticated-orcid":false,"given":"Mladen I.","family":"Vidovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.09.003_bb0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJMsb0803929","article-title":"Ethical and scientific implications of the globalization of clinical research","volume":"360","author":"Glickman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0010","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1001\/jamainternmed.2014.4762","article-title":"Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis","volume":"174","author":"Pancholy","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1161\/CIRCULATIONAHA.115.017299","article-title":"Trends in enrollment, clinical characteristics, treatment, and outcomes according to age in non\u2013ST-segment elevation acute coronary syndromes clinical trials","volume":"133","author":"Kragholm","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0020","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.113.001437","article-title":"Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and Centers for Medicare & Medicaid services payer databases","volume":"127","author":"Kumar","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0025","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.09.003_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2017.09.003_bb0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(10)62036-3","article-title":"National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants","volume":"377","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.09.003_bb0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","article-title":"National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants","volume":"377","author":"Farzadfar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.09.003_bb0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2013.284692","article-title":"Smoking prevalence and cigarette consumption in 187 countries, 1980-2012","volume":"311","author":"Ng","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.09.003_bb0055","first-page":"e29","article-title":"Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0060","doi-asserted-by":"crossref","first-page":"e001650","DOI":"10.1161\/JAHA.114.001650","article-title":"Changes in Cardiovascular Health in the United States, 2003-2011","volume":"4","author":"Pilkerton","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2017.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","article-title":"Epidemic obesity and type 2 diabetes in Asia","volume":"368","author":"Yoon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.09.003_bb0070","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.09.003_bb0075","first-page":"185","article-title":"Prevalence trends in lifestyle-related risk factors","volume":"112","author":"Volzke","year":"2015","journal-title":"Dtsch Arztebl Int"},{"issue":"Suppl. 2","key":"10.1016\/j.ahj.2017.09.003_bb0080","first-page":"S8","article-title":"Obesity, emerging risk in China: trend of increasing prevalence of obesity and its association with hypertension and hypercholesterolaemia among the Chinese","volume":"31","author":"Liu","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ahj.2017.09.003_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.diabres.2013.11.007","article-title":"Diabetes in Europe: an update","volume":"103","author":"Tamayo","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2017.09.003_bb0090","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1161\/CIRCULATIONAHA.111.070722","article-title":"Cardiovascular health behavior and health factor changes (1988-2008) and projections to 2020: results from the National Health and Nutrition Examination Surveys","volume":"125","author":"Huffman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0095","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1161\/hc4701.099488","article-title":"Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies","volume":"104","author":"Yusuf","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.ahj.2017.09.003_bb0105","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2017.09.003_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v036.i03","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ahj.2017.09.003_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ahj.2012.06.006","article-title":"Implications of geographical variation on clinical outcomes of cardiovascular trials","volume":"164","author":"Mentz","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.09.003_bb0120","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1093\/ejcts\/ezu197","article-title":"Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry","volume":"47","author":"Head","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ahj.2017.09.003_bb0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2014.6217","article-title":"Clinical trial participation after myocardial infarction in a national cardiovascular data registry","volume":"312","author":"Udell","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.09.003_bb0130","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0195-668X(03)00433-0","article-title":"International differences in in-hospital revascularization and outcomes following acute myocardial infarction: a multilevel analysis of patients in ASSENT-2","volume":"24","author":"Gupta","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.09.003_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCOUTCOMES.114.001239","article-title":"Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry","volume":"8","author":"Yeh","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2017.09.003_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e3181625d78","article-title":"Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials","volume":"87","author":"Braunstein","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ahj.2017.09.003_bb0145","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2010.03.013","article-title":"Association of insurance status with inpatient treatment for coronary artery disease: findings from the Get With the Guidelines program","volume":"159","author":"Vidovich","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.09.003_bb0150","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1200\/JCO.2002.08.056","article-title":"How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials","volume":"20","author":"Sateren","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ahj.2017.09.003_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ccl.2007.12.015","article-title":"Differences in European and North American approaches to the management of heart failure","volume":"26","author":"Poole-Wilson","year":"2008","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ahj.2017.09.003_bb0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2012.10.046","article-title":"Patient- and trial-specific barriers to participation in cardiovascular randomized clinical trials","volume":"61","author":"Martin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.09.003_bb0165","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/archinte.162.15.1682","article-title":"Representation of the elderly, women, and minorities in heart failure clinical trials","volume":"162","author":"Heiat","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0170","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCOUTCOMES.110.868307","article-title":"Representation of women in randomized clinical trials of cardiovascular disease prevention","volume":"3","author":"Melloni","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ahj.2017.09.003_bb0175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJM200008173430706","article-title":"Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute","volume":"343","author":"Harris","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0180","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1001\/jamainternmed.2014.4758","article-title":"Underrepresentation of women, elderly patients, and racial minorities in the randomized trials used for cardiovascular guidelines","volume":"174","author":"Sardar","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0185","first-page":"11146","volume":"59","year":"1994","journal-title":"Fed Regist"},{"key":"10.1016\/j.ahj.2017.09.003_bb0190","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1002\/cncr.28168","article-title":"Inclusion of minorities and women in cancer clinical trials, a decade later: have we improved?","volume":"119","author":"Kwiatkowski","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ahj.2017.09.003_bb0195","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature10405","article-title":"Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk","volume":"478","author":"International Consortium for Blood Pressure Genome-Wide Association S","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ahj.2017.09.003_bb0200","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/j.ajkd.2013.05.024","article-title":"Population ancestry and genetic risk for diabetes and kidney, cardiovascular, and bone disease: modifiable environmental factors may produce the cures","volume":"62","author":"Freedman","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ahj.2017.09.003_bb0205","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(09)60319-6","article-title":"Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis","volume":"373","author":"Trikalinos","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.09.003_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jacc.2013.09.061","article-title":"Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"63","author":"Palmerini","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.09.003_bb0215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2015.10.037","article-title":"Generalizability of SPRINT results to the U.S. adult population","volume":"67","author":"Bress","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.09.003_bb0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ahj.2014.12.001","article-title":"Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators","volume":"169","author":"Butler","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2017.09.003_bb0225","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1093\/eurheartj\/ehv203","article-title":"Report of a European Society of Cardiology\u2013European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary","volume":"36","author":"Byrne","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.09.003_bb0230","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/clpt.2013.70","article-title":"Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective","volume":"94","author":"Khin","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ahj.2017.09.003_bb0235","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1001\/jama.1995.03520440040034","article-title":"Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries","volume":"273","author":"Van de Werf","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.09.003_bb0240","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/CIRCULATIONAHA.111.047498","article-title":"Ticagrelor compared with clopidogrel by geographic region in the Platelet Inhibition and Patient Outcomes (PLATO) trial","volume":"124","author":"Mahaffey","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.09.003_bb0245","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMsb1300760","article-title":"Randomized clinical trials\u2014removing unnecessary obstacles","volume":"369","author":"Reith","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.09.003_bb0250","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2013.03.022","article-title":"Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review","volume":"166","author":"Zhang","year":"2013","journal-title":"Am Heart J"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:59:01Z","timestamp":1757570341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317302740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"alternative-id":["S0002870317302740"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.09.003","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global geographical variation in patient characteristics in percutaneous coronary intervention clinical trials: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}